Skip to main content
Equibles

BARCLAYS PLC

Position in TBPH — Theravance Biopharma, Inc.

CIK 312069 LONDON, X0
Back to TBPH Full portfolio

Position in TBPH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$722,925
-$29,757 QoQ
Shares Held
42,525
-8.3% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. TBPH ranks #135 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in TBPH

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $722,925 42,525
2026-03-31 $752,682 46,376
2025-12-31 $2,088,391 111,619
2025-09-30 $1,684,708 115,391
2025-06-30 $1,453,775 131,802
2025-03-31 $464,654 52,033
2024-12-31 $703,773 74,790
2024-09-30 $528,574 65,580
2024-06-30 $146,398 17,264
2024-03-31 $403,748 45,011
2023-12-31 $925,692 82,357
2023-09-30 $200,811 23,269
2023-06-30 $298,317 28,823
2023-03-31 $397,131 36,602
2022-12-31 $265,050 23,623
2022-09-30 $113,547 11,198
2022-06-30 $189,961 20,967
2022-03-31 $273,645 28,624
2021-12-31 $1,043,219 94,409
2021-09-30 $435,045 58,790
2021-06-30 $99,722 6,868
2021-03-31 $1,047,440 51,320
2020-12-31 $463,868 26,104
2020-09-30 $637,528 43,120
2020-06-30 $1,495,411 71,244
2020-03-31 $1,005,816 43,523